| Financial Year |
March 31 2023 |
| Monetary Funds |
2,270,680,758.35 |
| Held-for-trading Financial Assets |
120,774,000.00 |
| Notes Receivable |
653,854.94 |
| Accounts Receivable |
1,148,384,441.01 |
| Advances to Suppliers |
256,274,907.73 |
| Other Receivables |
218,314,814.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
964,405,448.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
97,682,025.67 |
| Total Current Assets |
5,446,575,420.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
83,678,518.96 |
| Fixed Assetes |
2,601,394,083.00 |
| Under-construction Projects |
827,831,920.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,670,314.86 |
| R&D expenses |
-- |
| Goodwill |
264,841,984.63 |
| Long-Term Deferred and Prepaid Expenses |
12,658,046.01 |
| Deferred Income Tax Assets |
68,392,921.87 |
| Other Non-Current Assets |
231,664,247.01 |
| Sub-Total of Non-Current Assets |
4,352,207,821.60 |
| Total Assets |
9,798,783,242.36 |
| Short-Term Loans |
1,631,197,941.64 |
| Trading Financial liabilities |
598,558.09 |
| Notes Payable |
1,007,566,044.01 |
| Accounts Payable |
205,626,680.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,393,778.51 |
| Taxes Payable |
26,470,323.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
217,472,811.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,616,503.37 |
| Other Current Liabilities |
2,165,118.76 |
| Sub-Total of Current Liabilities |
3,188,877,898.15 |
| Long-term Loans |
356,691,797.65 |
| Bonds Payable |
612,469,844.20 |
| Long-Term Accounts Payable |
202,943.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,816,609.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,075,485,845.01 |
| Total Liabilities |
4,264,363,743.16 |
| Paid-In Capital(Or Share Stock) |
909,854,275.00 |
| Capital Surplus |
3,661,009,549.06 |
| Surplus Reserve |
73,852,619.67 |
| LESS:Treasury Stock |
102,571,680.50 |
| Undistributed Profits |
994,281,564.08 |
| Minority Stockholder's Interest |
13,771,524.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,520,647,974.53 |
| Owner's Equity（Stockholder's Equity） |
5,534,419,499.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,798,783,242.36 |
